News

Paratek Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results and Provides Clinical Update

BOSTON, May 04, 2017 (GLOBE NEWSWIRE) — ┬áParatek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today reported financial results for the quarter ended March 31, 2017.

2017-06-21T11:10:52+00:00